KB Medical Group

Executive Summary

KB Medical Group (KBMED), a global leader in specimen collection, oncology therapy, and enteral nutrition products, leverages 40 years of industry experience and state-of-the-art manufacturing to deliver innovative safety medical devices. Operating with over 700 employees across three subsidiaries, the company partners with clients to develop tailored solutions that address specific healthcare needs. As a private entity headquartered in San Jose, California, KBMED has established a strong foothold in the medical devices sector, particularly in oncology and nutritional support, which positions it well for growth amid rising demand for minimally invasive and patient-centric technologies. The company’s expertise in safety devices and its global supply chain enable it to serve diverse markets, from hospitals to home care settings, ensuring resilience and adaptability in a competitive landscape. With a focus on innovation and quality, KB Medical Group is poised to capture opportunities in emerging therapeutic areas and expand its geographic reach.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Next-Generation Oncology Therapy Device75% success
• Q3 2026Launch of Enhanced Specimen Collection System for Liquid Biopsy80% success
• Q3 2026Strategic Partnership or Distribution Agreement in Asia-Pacific Region60% success